Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 942-947

  Doi, Takehiko ^a,b   Shimada, Hiroyuki ^a   Makizako, Hyuma ^a,b   Tsutsumimoto, Kota ^a   Hotta, Ryo ^a   Nakakubo, Sho ^a   Suzuki, Takao ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b Japan Society for the Promotion of Sience   (Japan)

Author keywords

Cognitive function; Gait speed; IGF 1; MCI

Indexed keywords

SOMATOMEDIN C;

AGED; ARTICLE; ATTENTION; BLOOD LEVEL; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL ASSESSMENT; GAIT DISORDER; GAIT SPEED; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; VELOCITY; BRAIN; COGNITION; EXERCISE; GAIT; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

AGED; BRAIN; COGNITION; EXERCISE; FEMALE; GAIT; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MILD COGNITIVE IMPAIRMENT;

EID: 84922923630     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.035     Document Type: Article

References (56)

1. Adem A., Jossan S.S., d'Argy R., Gillberg P.G., Nordberg A., Winblad B., Sara V. Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res. 1989, 503:299-303.
2. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:270-279.
3. Aleman A., Torres-Aleman I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog. Neurobiol. 2009, 89:256-265.
4. Angelini A., Bendini C., Neviani F., Bergamini L., Manni B., Trenti T., Rovati R., Neri M. Insulin-like growth factor-1 (IGF-1): relation with cognitive functioning and neuroimaging marker of brain damage in a sample of hypertensive elderly subjects. Arch. Gerontol. Geriatr. 2009, 49(Suppl 1):5-12.
5. Arwert L.I., Deijen J.B., Drent M.L. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Hormone IGF Res. 2005, 15:416-422.
6. Baker L.D., Barsness S.M., Borson S., Merriam G.R., Friedman S.D., Craft S., Vitiello M.V. Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch. Neurol. 2012, 69:1420-1429.
7. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
8. Barbieri M., Ferrucci L., Ragno E., Corsi A., Bandinelli S., Bonafe M., Olivieri F., Giovagnetti S., Franceschi C., Guralnik J.M., Paolisso G. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E481-E487.
9. Bondy C.A., Cheng C.M. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 2004, 490:25-31.
10. Buchman A.S., Yu L., Wilson R.S., Schneider J.A., Bennett D.A. Association of brain pathology with the progression of frailty in older adults. Neurology 2013, 80:2055-2061.
11. Buracchio T., Dodge H.H., Howieson D., Wasserman D., Kaye J. The trajectory of gait speed preceding mild cognitive impairment. Arch. Neurol. 2010, 67:980-986.
12. Cappola A.R., Bandeen-Roche K., Wand G.S., Volpato S., Fried L.P. Association of IGF-I levels with muscle strength and mobility in older women. J.Clin. Endocrinol. Metab. 2001, 86:4139-4146.
13. Carro E., Trejo J.L., Gerber A., Loetscher H., Torrado J., Metzger F., Torres-Aleman I. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol. Aging 2006, 27:1250-1257.
14. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 2002, 8:1390-1397.
15. Clegg A., Young J., Iliffe S., Rikkert M.O., Rockwood K. Frailty in elderly people. Lancet 2013, 381:752-762.
16. Cotman C.W., Berchtold N.C., Christie L.A. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 2007, 30:464-472.
17. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J.Alzheimers Dis. 2005, 7:45-61.
18. Deak F., Sonntag W.E. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J.Gerontol. A Biol. Sci. Med. Sci. 2012, 67:611-625.
19. Dik M.G., Pluijm S.M., Jonker C., Deeg D.J., Lomecky M.Z., Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol. Aging 2003, 24:573-581.
20. Dore S., Kar S., Quirion R. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4772-4777.
21. Duron E., Funalot B., Brunel N., Coste J., Quinquis L., Viollet C., Belmin J., Jouanny P., Pasquier F., Treluyer J.M., Epelbaum J., le Bouc Y., Hanon O. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease. J.Clin. Endocrinol. Metab. 2012, 97:4673-4681.
22. Florini J.R., Ewton D.Z., Magri K.A. Hormones, growth factors, and myogenic differentiation. Annu. Rev. Physiol. 1991, 53:201-216.
23. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J.Psychiatr. Res. 1975, 12:189-198.
24. Hong M., Lee V.M. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J.Biol. Chem. 1997, 272:19547-19553.
25. Jafferali S., Dumont Y., Sotty F., Robitaille Y., Quirion R., Kar S. Insulin-like growth factor-I and its receptor in the frontal cortex, hippocampus, and cerebellum of normal human and Alzheimer disease brains. Synapse 2000, 38:450-459.
26. Johansson P., Aberg D., Johansson J.O., Mattsson N., Hansson O., Ahren B., Isgaard J., Aberg N.D., Blennow K., Zetterberg H., Wallin A., Svensson J. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease. Psychoneuroendocrinology 2013, 38:1729-1737.
27. Kalmijn S., Janssen J.A., Pols H.A., Lamberts S.W., Breteler M.M. Aprospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J.Clin. Endocrinol. Metab. 2000, 85:4551-4555.
28. Kaplan R.C., McGinn A.P., Pollak M.N., Kuller L., Strickler H.D., Rohan T.E., Xue X., Kritchevsky S.B., Newman A.B., Psaty B.M. Total insulin-like growth factor 1 and insulin-like growth factor binding protein levels, functional status, and mortality in older adults. J.Am. Geriatr. Soc. 2008, 56:652-660.
29. Liu-Ambrose T., Nagamatsu L.S., Voss M.W., Khan K.M., Handy T.C. Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial. Neurobiol. Aging 2012, 33:1690-1698.
30. Lopez-Lopez C., LeRoith D., Torres-Aleman I. Insulin-like growth factor I is required for vessel remodeling in the adult brain. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9833-9838.
31. Makizako H., Shimada H., Park H., Doi T., Yoshida D., Uemura K., Tsutsumimoto K., Suzuki T. Evaluation of multidimensional neurocognitive function using a tablet personal computer: test-retest reliability and validity in community-dwelling older adults. Geriatr. Gerontol. Int. 2013, 13:860-866.
32. Mielke M.M., Roberts R.O., Savica R., Cha R., Drubach D.I., Christianson T., Pankratz V.S., Geda Y.E., Machulda M.M., Ivnik R.J., Knopman D.S., Boeve B.F., Rocca W.A., Petersen R.C. Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J.Gerontol. A Biol. Sci. Med. Sci. 2013, 68:929-937.
33. Mikami S., Hamano T., Fujii N., Nagasawa Y., Isaka Y., Moriyama T., Matsuhisa M., Ito T., Imai E., Hori M. Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens. Res. 2008, 31:1163-1170.
34. Murase N., Katsumura T., Ueda C., Inoue S., Shimomitsu T. International standardization of physical activity level: reliability and validity study of the Japanese version of the International Physical Activity Questionnaire (IPAQ) (Kosei no Shihyo). J.Health Welfare Stat. 2003, 49:9.
35. Nishijima T., Piriz J., Duflot S., Fernandez A.M., Gaitan G., Gomez-Pinedo U., Verdugo J.M., Leroy F., Soya H., Nunez A., Torres-Aleman I. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67:834-846.
36. Onder G., Liperoti R., Russo A., Soldato M., Capoluongo E., Volpato S., Cesari M., Ameglio F., Bernabei R., Landi F. Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E829-E834.
37. Peters D.M., Fritz S.L., Krotish D.E. Assessing the reliability and validity of a shorter walk test compared with the 10-Meter Walk Test for measurements of gait speed in healthy, older adults. J.Geriatr. Phys. Ther. 2013, 36:24-30.
38. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J.Intern. Med. 2004, 256:183-194.
39. Petersen R.C. Clinical practice. Mild cognitive impairment. N.Engl. J. Med. 2011, 364:2227-2234.
40. Sanders J.L., Ding V., Arnold A.M., Kaplan R.C., Cappola A.R., Kizer J.R., Boudreau R.M., Cushman M., Newman A.B. Do changes in circulating biomarkers track with each other and with functional changes in older adults?. J.Gerontol. A Biol. Sci. Med. Sci. 2014, 69:174-181.
41. Shimada H., Makizako H., Doi T., Yoshida D., Tsutsumimoto K., Anan Y., Uemura K., Ito T., Lee S., Park H., Suzuki T. Combined prevalence of frailty and mild cognitive impairment in a population of elderly Japanese people. J.Am. Med. Dir. Assoc. 2013, 14:518-524.
42. Shimada H., Suzuki T., Suzukawa M., Makizako H., Doi T., Yoshida D., Tsutsumimoto K., Anan Y., Uemura K., Ito T., Lee S., Park H. Performance-based assessments and demand for personal care in older Japanese people: a cross-sectional study. BMJ Open 2013, 3:e002424.
43. Shum D.H.K., McFarland K.A., Bain J.D. Construct validity of eight tests of attention: comparison of normal and closed head injured samples. Clin. Neuropsychol. 1990, 4:151-162.
44. Solfrizzi V., Scafato E., Frisardi V., Seripa D., Logroscino G., Maggi S., Imbimbo B.P., Galluzzo L., Baldereschi M., Gandin C., Di Carlo A., Inzitari D., Crepaldi G., Pilotto A., Panza F. Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging. Alzheimers Dement. 2013, 9:113-122.
45. Sonntag W.E., Ramsey M., Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res. Rev. 2005, 4:195-212.
46. Trejo J.L., Carro E., Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J.Neurosci. 2001, 21:1628-1634.
47. Trejo J.L., Llorens-Martin M.V., Torres-Aleman I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol. Cell. Neurosci. 2008, 37:402-411.
48. van Dam P.S., Aleman A., de Vries W.R., Deijen J.B., van der Veen E.A., de Haan E.H., Koppeschaar H.P. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm. IGF Res. 2000, 10(Suppl B):S69-S73.
49. van Exel E., Eikelenboom P., Comijs H., Deeg D.J., Stek M.L., Westendorp R.G. Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings from a family study. Neurobiol. Aging 2014, 35:e7-10.
50. Vardy E.R., Rice P.J., Bowie P.C., Holmes J.D., Grant P.J., Hooper N.M. Increased circulating insulin-like growth factor-1 in late-onset Alzheimer's disease. Journal of Alzheimer's disease. J.Alzheimers Dis. 2007, 12:285-290.
51. Verghese J., Annweiler C., Ayers E., Barzilai N., Beauchet O., Bennett D.A., Bridenbaugh S.A., Buchman A.S., Callisaya M.L., Camicioli R., Capistrant B., Chatterji S., De Cock A.M., Ferrucci L., Giladi N., Guralnik J.M., Hausdorff J.M., Holtzer R., Kim K.W., Kowal P., Kressig R.W., Lim J.Y., Lord S., Meguro K., Montero-Odasso M., Muir-Hunter S.W., Noone M.L., Rochester L., Srikanth V., Wang C. Motoric cognitive risk syndrome: Multicountry prevalence and dementia risk. Neurology 2014, 83:718-726.
52. Voss M.W., Vivar C., Kramer A.F., van Praag H. Bridging animal and human models of exercise-induced brain plasticity. Trends Cogn. Sci. 2013, 17:525-544.
53. Waite L.M., Grayson D.A., Piguet O., Creasey H., Bennett H.P., Broe G.A. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J.Neurol. Sci. 2005, 229-230:89-93.
54. Watanabe T., Miyazaki A., Katagiri T., Yamamoto H., Idei T., Iguchi T. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. J.Am. Geriatr. Soc. 2005, 53:1748-1753.
55. Westwood A.J., Beiser A., Decarli C., Harris T.B., Chen T.C., He X.M., Roubenoff R., Pikula A., Au R., Braverman L.E., Wolf P.A., Vasan R.S., Seshadri S. Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 2014, 82:1613-1619.
56. Yesavage J.A. Geriatric depression scale. Psychopharmacol. Bull. 1988, 24:709-711.